Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 397 of modules/custom/futures_option/src/Controller/FuturesController.php).
  1. Home
  2. Stocks
  3. Jagsnpharm Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Jagsonpal Pharmaceuticals

    Small Cap
    ₹326.1
    -6.2 (-1.87%)
    01 June, 2024 10:09 BSE: 507789 NSE: JAGSNPHARMISIN: INE048B01027

    Start SIP in Jagsonpal Pharmaceuticals

    Start SIP

    Jagsonpal Pharmaceuticals Performance

    Day Range

    • Low 318
    • High 342
    ₹ 326

    52 Week Range

    • Low 274
    • High 515
    ₹ 326
    • Open Price335
    • Previous Close332
    • Volume53293

    Jagsonpal Pharmaceuticals Share Price

    • Over 1 Month -9.81%
    • Over 3 Month +9.39%
    • Over 6 Month -21.7%
    • Over 1 Year -10.53%

    Jagsonpal Pharmaceuticals Key Statistics

    P/E Ratio 38.4
    PEG Ratio -5.4
    Market Cap Cr 862
    Price to Book Ratio 4.6
    EPS 8.5
    Dividend 1.5
    Relative Strength Index 46.09
    Money Flow Index 67.82
    MACD Signal 4.87
    Average True Range 16.97
    Jagsonpal Pharmaceuticals Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 4347586055
    Operating Expenses Qtr Cr 4144495250
    Operating Profit Qtr Cr 33895
    Depreciation Qtr Cr 00000
    Interest Qtr Cr 00000
    Tax Qtr Cr 11232
    Net Profit Qtr Cr 44776
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 218242
    Operating Expenses Annual Cr 186203
    Operating Profit Annual in Cr 2334
    Depreciation Cr 21
    Interest Annual Cr 10
    Tax Annual Cr 78
    Net Profit Annual Cr 2227
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 3547
    Cash from Investing Activity Annual Cr -25-58
    Cash from Financing Annual Activity Cr -90
    Net Cash Flow Annual Cr -11
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 187159
    Fixed Assets Annual Cr 924
    Total Non Current Assets Annual Cr 1830
    Total Current Assets Annual Cr 199165
    Total Assets Annual Cr 217195
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 7161
    ROE Annual % 1217
    ROCE Annual % 1623
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1517
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in Jagsonpal Pharmaceuticals

    Jagsonpal Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹326.1
    -6.2 (-1.87%)
    pointer
    • Bullish Moving Average
    • ___
    • 1
    • Bearish Moving Average
    • ___
    • 15
    • 20 Day
    • ₹336.01
    • 50 Day
    • ₹330.26
    • 100 Day
    • ₹336.48
    • 200 Day
    • ₹349.57
    • 20 Day
    • ₹336.52
    • 50 Day
    • ₹320.84
    • 100 Day
    • ₹328.59
    • 200 Day
    • ₹371.58

    Jagsonpal Pharmaceuticals Resistance and Support

    PIVOT
    ₹328.59
    Resistance
    First Resistance 339.67
    Second Resistance 353.23
    Third Resistance 364.32
    RSI 46.09
    MFI 67.82
    MACD Single Line 4.87
    MACD 2.40
    Support
    First Support 315.02
    Second Support 303.93
    Third Supoort 290.37

    Jagsonpal Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 55,652 3,646,876 65.53
    Week 33,010 1,872,020 56.71
    1 Month 43,350 1,916,501 44.21
    6 Month 46,482 2,688,534 57.84

    Jagsonpal Pharmaceuticals Result Highlights

    Jagsonpal Pharmaceuticals Synopsis

    NSE-Medical-Diversified

    Jagsonpal Pharma is involved in the business activities of Manufacture of homoeopathic or biochemic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 236.71 Cr. and Equity Capital is Rs. 13.10 Cr. for the Year ended 31/03/2023. Jagsonpal Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 17/08/1978 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1978PLC009181 and registration number is 009181.
    Market Cap 862
    Sales 209
    Shares in Float 0.85
    No of funds 8
    Yield 1.47
    Book Value 4.6
    U/D Vol ratio 2.1
    LTDebt / Equity
    Alpha -0.09
    Beta 0.86

    Jagsonpal Pharmaceuticals Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 68.09%68.48%68.71%68.71%
    Mutual Funds
    Foreign Portfolio Investors 0.73%0.53%0.38%0.37%
    Financial Institutions/ Banks
    Individual Investors 20.68%21.94%21.99%22.84%
    Others 10.5%9.05%8.92%8.08%

    Jagsonpal Pharmaceuticals Management

    Name Designation
    Mr. Rajpal Singh Kochhar Chairman Emeritus
    Mr. Manish Gupta Managing Director
    Mr. Harsha Raghavan Chairman & Non-Exe.Director
    Mr. Prithipal Singh Kochhar Non Executive Director
    Mr. Debasis Bikash Nandy Independent Director
    Ms. Radhika Madhukar Dudhat Independent Director
    Ms. Pallavi Dinodia Gupta Independent Director

    Jagsonpal Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Jagsonpal Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-05-20 Audited Results & Final Dividend
    2024-02-02 Quarterly Results
    2023-11-03 Quarterly Results
    2023-08-02 Quarterly Results
    2023-05-23 Audited Results & Dividend
    Date Purpose Remarks
    2023-08-21 FINAL Rs.5.00 per share(100%)Dividend
    2021-11-01 INTERIM Rs.4.00 per share(80%)Interim Dividend

    Jagsonpal Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Jagsonpal Pharmaceuticals FAQs

    What is Share Price of Jagsonpal Pharmaceuticals ?

    Jagsonpal Pharmaceuticals share price is ₹326 As on 01 June, 2024 | 09:55

    What is the Market Cap of Jagsonpal Pharmaceuticals ?

    The Market Cap of Jagsonpal Pharmaceuticals is ₹862.2 Cr As on 01 June, 2024 | 09:55

    What is the P/E ratio of Jagsonpal Pharmaceuticals ?

    The P/E ratio of Jagsonpal Pharmaceuticals is 38.4 As on 01 June, 2024 | 09:55

    What is the PB ratio of Jagsonpal Pharmaceuticals ?

    The PB ratio of Jagsonpal Pharmaceuticals is 4.6 As on 01 June, 2024 | 09:55

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.